Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung Cancer
Clinical trial NCT04173325 · TERMINATED
Trial details
- NCT number
- NCT04173325
- Sponsor
- Augusta University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-06
- Primary completion
- 2022-05-26
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.